Cornell researchers have confirmed that a previously identified biomarker for detecting the presence of malignant testicular germ cell tumors—the most common solid cancers in young men—has the potential to improve patient outcomes through early detection, possibly even prenatally.
This article was originally published on MedicalXpress.com